EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients-Reference-Cited by-同舟云学术

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients

Published:2013-06-18 Issue:10 Volume:121 Page:552-560
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Malapelle Umberto¹,Bellevicine Claudio¹,De Luca Caterina¹,Salatiello Maria¹,De Stefano Alfonso²,Rocco Danilo³,de Rosa Nicla³,Vitiello Fabiana³,Russo Stefania¹,Pepe Francesco¹,Iaccarino Antonino¹,Micheli Pietro³,Illiano Alfonso³,Carlomagno Chiara²,Piantedosi Franco Vito³,Troncone Giancarlo¹

Affiliation:

1. Department of Public Health; University of Naples Federico II; Naples Italy

2. Department of Oncology; University of Naples Federico II; Naples Italy

3. Department of Oncology and Anatomic Pathology; Hospital of National Relevance (AORN) Vincenzo Monaldi; Naples Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncy.21322/fullpdf

Reference26 articles.

1. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities;Cunha Santos;Cancer Cytopathol,2011